Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Nestorone Testosterone Combination Gel

Research Leaders

5 sponsors active, led by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 25/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT02994602Phase 1Completed

Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males

Showing all 1 trials

Research Network

Common Treatments

  • Nestorone Testosterone Combination Gel1

Active Sponsors

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1
  • University of Washington1
  • Population Council1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Kimberly Myer1

Top Investigators

Related Conditions

  • Healthy Men1
  • Male Contraception1
  • Healthy Women1

Activity Timeline